Loop Dx
Loop Diagnostics is a biotech company dedicated to developing innovative diagnostic tools for early detection of sepsis. Their mission is to reduce disease severity and mortality rates through timely and effective treatment, utilizing advanced in vitro cellular immunoassay technology. The company aims to provide healthcare professionals with rapid, accurate, and accessible diagnostic solutions to improve patient outcomes.
Industries
Nr. of Employees
small (1-50)
Loop Dx
c. de Santander 45, Piso 2 08020, Barcelona, Spain
Products
SeptiLoop
A lateral-flow in vitro diagnostic assay designed to detect bloodstream infection by measuring patient immune-activity biomarkers; intended for point-of-care use with rapid time-to-result.
SeptiLoop
A lateral-flow in vitro diagnostic assay designed to detect bloodstream infection by measuring patient immune-activity biomarkers; intended for point-of-care use with rapid time-to-result.
Services
Design and execution of clinical proof-of-concept and multicenter prospective trials to validate diagnostic performance in septic patients.
R&D services covering identification and analytical validation of immune-activity biomarkers and development of cellular immunoassays.
Preparation of technical files and documentation for regulatory pathways including CE marking, UKCA, and planned FDA De Novo interactions.
Development of MVPs, industrial prototypes and industrial pilot production to transition assays to manufacturable IVD devices.
Design and execution of clinical proof-of-concept and multicenter prospective trials to validate diagnostic performance in septic patients.
R&D services covering identification and analytical validation of immune-activity biomarkers and development of cellular immunoassays.
Preparation of technical files and documentation for regulatory pathways including CE marking, UKCA, and planned FDA De Novo interactions.
Development of MVPs, industrial prototypes and industrial pilot production to transition assays to manufacturable IVD devices.
Expertise Areas
- Early sepsis diagnostics
- Point-of-care lateral-flow diagnostics
- Immune-response biomarker discovery and validation
- Clinical trial design and execution for diagnostic devices
Key Technologies
- Lateral-flow immunoassay
- Cellular immunoassay
- Point-of-care diagnostic devices
- Algorithmic biomarker analysis engine